Targeted anal cancer screening in HIV-infected patients: Prevalence of screening indicators

AIDS

Volumn 23, Issue 12, 2009, Pages 1613-1615

  Shalev, Noga ^a,c   Olender, Susan A ^a   Chiasson, Mary Ann ^b  

^a Department of Medicine   (United States)

^b Public Health Solutions   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANUS CANCER; CANCER SCREENING; CYTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANUS NEOPLASMS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; RISK FACTORS;

EID: 68649125361     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832e3453     Document Type: Letter

References (14)

1. Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist 2007; 12:524-534.
2. Klencke BJ, Palefsky JM. Anal cancer: an HlV-associated cancer. Hematol Oncol Clin North Am 2003; 17:859-872.
3. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, et al. Incidence of types of cancer among HIV-Infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148: 728-736.
4. Palefsky JM, Holly EA, Ralston MM, Da Costa M, Bonner H, Jay N, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: Prevalence and risk factors. J. Acquir Immune Defic Syndr Hum Retrovir 1998; 17:320-326.
5. Etienney I, Vuong S, Daniel F, Mory B, Taouk M, Sultan S, et al. Prevalence of anal cytologic abnormalities in a French referral population: a prospective study with special emphasis on HIV, HPV, and smoking. Dis Colon Rectum 2008; 51:67-72.
6. Cranston RD, Hart SD, Gornbein JA, Hirschowitz SL, Cortina G, Moe AA. The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia in a population of HI V-positive men who have sex with men. Int J STD AIDS 2007; 18:77-80.
7. Arain S, Walts AE, Thomas P, Bose S. The anal pap smear: cytomorphology of squamous intraepithelial lesions. Cytojournal 2005; 2:4.
8. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006; 43:223-233.
9. http://www.hivguidelines.org/GuideLine.aspx?GuideLi-nelD=22#V. %20ANAL%20DYSPLASIA%20AND%20CAN-CER. [Accessed 25 March 2009]
10. Scott H, Koury J, Moore BA, Weissman S. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Trans Dis 2008; 35:197-202.
11. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. JID 2004; 190:1685-1781.
12. Piketty C, Sellinger-Leneman H, Grabar S, Duvivier, Bonmarc-hand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22:1203-1211.
13. Centers for Disease Control and Prevention. Guidelines for the Prevention and Treatment of opportunistic Infections in HIV-infected Adults and Adolescents. MMWR 2009; 58:71.
14. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV positive men. JAMA 1999; 281:1822-1829.